EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A

Allergy. 2019 Mar;74(3):613-617. doi: 10.1111/all.13651. Epub 2018 Dec 16.

Authors

Judith L Thijs^{1

2}, Julia Drylewicz², Carla A F M Bruijnzeel-Koomen¹, Barbara Giovannone^{1

2}, Edward F Knol^{1

2}, Marjolein S de Bruin-Weller¹, Stefan Nierkens^{2

3}, DirkJan Hijnen^{1

2}

Affiliations

¹ Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
² Laboratory of Translational Immunology, Utrecht, The Netherlands.
³ U-DAIR, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 30368864
DOI: 10.1111/all.13651

No abstract available

Publication types

Letter

MeSH terms

Cyclosporine / therapeutic use
Dermatitis, Atopic / diagnosis*
Dermatitis, Atopic / drug therapy
Dermatitis, Atopic / etiology
Disease Management
Humans
Immunosuppressive Agents / therapeutic use
Prognosis
Severity of Illness Index
Treatment Outcome

Substances

Immunosuppressive Agents
Cyclosporine